Published in Hum Gene Ther Methods on March 21, 2014
Site-Specific Genome Engineering in Human Pluripotent Stem Cells. Int J Mol Sci (2016) 0.82
Defined three-dimensional culture conditions mediate efficient induction of definitive endoderm lineage from human umbilical cord Wharton's jelly mesenchymal stem cells. Stem Cell Res Ther (2016) 0.75
Modulation of cardiomyocyte activity using pulsed laser irradiated gold nanoparticles. Biomed Opt Express (2016) 0.75
Comparison of Different Electroporation Parameters on Transfection Efficiency of Sheep Testicular Cells. Cell J (2016) 0.75
EBIO Does Not Induce Cardiomyogenesis in Human Pluripotent Stem Cells but Modulates Cardiac Subtype Enrichment by Lineage-Selective Survival. Stem Cell Reports (2017) 0.75
Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods (2001) 414.27
Embryonic stem cell lines from human blastocysts: somatic differentiation in vitro. Nat Biotechnol (2000) 12.41
Homologous recombination in human embryonic stem cells. Nat Biotechnol (2003) 5.77
Genetically selected cardiomyocytes from differentiating embronic stem cells form stable intracardiac grafts. J Clin Invest (1996) 3.87
Clonal dominance of hematopoietic stem cells triggered by retroviral gene marking. Science (2005) 3.58
A universal system for highly efficient cardiac differentiation of human induced pluripotent stem cells that eliminates interline variability. PLoS One (2011) 3.39
Retroviral expression in embryonic stem cells and hematopoietic stem cells. Mol Cell Biol (2000) 3.20
Generation of induced pluripotent stem cells from human cord blood. Cell Stem Cell (2009) 2.78
A method for genetic modification of human embryonic stem cells using electroporation. Nat Protoc (2007) 2.76
Cellular differentiation hierarchies in normal and culture-adapted human embryonic stem cells. Hum Mol Genet (2005) 2.66
Lentiviral vectors and protocols for creation of stable hESC lines for fluorescent tracking and drug resistance selection of cardiomyocytes. PLoS One (2009) 2.62
High-level sustained transgene expression in human embryonic stem cells using lentiviral vectors. Stem Cells (2003) 2.42
Transgenes delivered by lentiviral vector are suppressed in human embryonic stem cells in a promoter-dependent manner. Stem Cells Dev (2007) 2.27
Identification and selection of cardiomyocytes during human embryonic stem cell differentiation. FASEB J (2007) 2.10
Origins and implications of pluripotent stem cell variability and heterogeneity. Nat Rev Mol Cell Biol (2013) 1.91
Transient and stable transgene expression in human embryonic stem cells. Stem Cells (2007) 1.91
Functional analysis of various promoters in lentiviral vectors at different stages of in vitro differentiation of mouse embryonic stem cells. Mol Ther (2007) 1.76
Lentiviral vectors with a defective integrase allow efficient and sustained transgene expression in vitro and in vivo. Proc Natl Acad Sci U S A (2006) 1.74
Enhanced cardiomyogenesis of human embryonic stem cells by a small molecular inhibitor of p38 MAPK. Differentiation (2007) 1.66
Critical factors influencing stable transduction of human CD34(+) cells with HIV-1-derived lentiviral vectors. Mol Ther (2000) 1.61
Chemically defined medium supporting cardiomyocyte differentiation of human embryonic stem cells. Differentiation (2008) 1.56
Human ESCs predisposition to karyotypic instability: Is a matter of culture adaptation or differential vulnerability among hESC lines due to inherent properties? Mol Cancer (2008) 1.55
Retrovirus silencing, variegation, extinction, and memory are controlled by a dynamic interplay of multiple epigenetic modifications. Mol Ther (2004) 1.54
Scalable expansion of human pluripotent stem cells in suspension culture. Nat Protoc (2011) 1.46
The hESC line Envy expresses high levels of GFP in all differentiated progeny. Nat Methods (2005) 1.35
Feeder-free culture of human embryonic stem cells in conditioned medium for efficient genetic modification. Nat Protoc (2008) 1.34
Induced pluripotent stem cell (iPSC)-derived Flk-1 progenitor cells engraft, differentiate, and improve heart function in a mouse model of acute myocardial infarction. Eur Heart J (2011) 1.29
A comparison of exogenous promoter activity at the ROSA26 locus using a ΦiC31 integrase mediated cassette exchange approach in mouse ES cells. PLoS One (2011) 1.29
Improved genetic manipulation of human embryonic stem cells. Nat Methods (2008) 1.29
Silencing of gene expression: implications for design of retrovirus vectors. Rev Med Virol (2001) 1.29
Long term non-invasive imaging of embryonic stem cells using reporter genes. Nat Protoc (2009) 1.27
Survival and maturation of human embryonic stem cell-derived cardiomyocytes in rat hearts. J Mol Cell Cardiol (2007) 1.23
Long term expansion of undifferentiated human iPS and ES cells in suspension culture using a defined medium. Stem Cell Res (2010) 1.20
Derivation and spontaneous differentiation of human embryonic stem cells. J Anat (2002) 1.19
Human embryonic stem cells: genetic manipulation on the way to cardiac cell therapies. Reprod Toxicol (2005) 1.14
The CMV early enhancer/chicken beta actin (CAG) promoter can be used to drive transgene expression during the differentiation of murine embryonic stem cells into vascular progenitors. BMC Cell Biol (2008) 1.12
Retrovirus silencing and vector design: relevance to normal and cancer stem cells? Curr Gene Ther (2005) 1.12
Small animal imaging with high resolution single photon emission tomography. Nucl Med Biol (2003) 1.09
A ubiquitous chromatin opening element prevents transgene silencing in pluripotent stem cells and their differentiated progeny. Stem Cells (2013) 1.09
Cellular endocytosis and gene delivery. Mol Med (2010) 1.08
Improved version of the red fluorescent protein (drFP583/DsRed/RFP). Biotechniques (2002) 1.08
Chemical vectors for gene delivery: uptake and intracellular trafficking. Curr Opin Biotechnol (2010) 1.08
Overview of stem cells and imaging modalities for cardiovascular diseases. J Nucl Cardiol (2006) 1.08
Quantitative comparison of constitutive promoters in human ES cells. PLoS One (2010) 1.08
Highly enriched cardiomyocytes from human embryonic stem cells. Cytotherapy (2008) 1.07
An engineered cardiac reporter cell line identifies human embryonic stem cell-derived myocardial precursors. PLoS One (2011) 1.05
Comparison of gene-transfer efficiency in human embryonic stem cells. Mol Imaging Biol (2009) 1.05
Forward programming of pluripotent stem cells towards distinct cardiovascular cell types. Cardiovasc Res (2009) 1.05
Efficient culturing and genetic manipulation of human pluripotent stem cells. PLoS One (2011) 0.97
Stable transgene expression in human embryonic stem cells after simple chemical transfection. Mol Reprod Dev (2009) 0.95
Specific and stable gene transfer to human embryonic stem cells using pseudotyped lentiviral vectors. Stem Cells Dev (2006) 0.92
Generation of optimized yellow and red fluorescent proteins with distinct subcellular localization. Biotechniques (2004) 0.92
Promoter and lineage independent anti-silencing activity of the A2 ubiquitous chromatin opening element for optimized human pluripotent stem cell-based gene therapy. Biomaterials (2013) 0.90
Cardiac-specific gene expression facilitated by an enhanced myosin light chain promoter. Mol Imaging (2004) 0.90
Directing cardiomyogenic differentiation of human pluripotent stem cells by plasmid-based transient overexpression of cardiac transcription factors. Stem Cells Dev (2013) 0.89
Functional human artificial chromosomes are generated and stably maintained in human embryonic stem cells. Hum Mol Genet (2011) 0.87
Efficient, high-throughput transfection of human embryonic stem cells. Stem Cell Res Ther (2010) 0.87
Non-viral episomal modification of cells using S/MAR elements. Expert Opin Biol Ther (2011) 0.84
Is reliable in vivo detection of stem cell viability possible in a large animal model of myocardial injury? Circulation (2012) 0.83
A practical synthesis of Rho-Kinase inhibitor Y-27632 and fluoro derivatives and their evaluation in human pluripotent stem cells. Org Biomol Chem (2011) 0.83
Genetic manipulation of human embryonic stem cells in serum and feeder-free media. Methods Mol Biol (2010) 0.79
Developing extrachromosomal gene expression vector technologies: an overview. Methods Mol Biol (2011) 0.78
Improved lentiviral gene transfer into human embryonic stem cells grown in co-culture with murine feeder and stroma cells. Biol Chem (2011) 0.78
Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. Eur Heart J (2005) 7.75
MicroRNAs in the human heart: a clue to fetal gene reprogramming in heart failure. Circulation (2007) 6.41
Genomic instability and myelodysplasia with monosomy 7 consequent to EVI1 activation after gene therapy for chronic granulomatous disease. Nat Med (2010) 4.76
Incidence and prognostic influence of DNMT3A mutations in acute myeloid leukemia. J Clin Oncol (2011) 3.17
Generation of functional murine cardiac myocytes from induced pluripotent stem cells. Circulation (2008) 3.11
The safety of moderate hypothermic lower body circulatory arrest with selective cerebral perfusion: a propensity score analysis. J Thorac Cardiovasc Surg (2007) 3.08
TP53 mutations in low-risk myelodysplastic syndromes with del(5q) predict disease progression. J Clin Oncol (2011) 2.88
Extracorporeal membrane oxygenation in awake patients as bridge to lung transplantation. Am J Respir Crit Care Med (2012) 2.86
Generation of induced pluripotent stem cells from human cord blood. Cell Stem Cell (2009) 2.78
Cryopreserved human allografts (homografts) for the management of graft infections in the ascending aortic position extending to the arch. Eur J Cardiothorac Surg (2012) 2.70
Frequency and prognostic impact of mutations in SRSF2, U2AF1, and ZRSR2 in patients with myelodysplastic syndromes. Blood (2012) 2.69
Impact of IDH1 R132 mutations and an IDH1 single nucleotide polymorphism in cytogenetically normal acute myeloid leukemia: SNP rs11554137 is an adverse prognostic factor. J Clin Oncol (2010) 2.38
Mechanisms underlying adverse effects of HDL on eNOS-activating pathways in patients with coronary artery disease. J Clin Invest (2011) 2.37
Prognostic significance of ASXL1 mutations in patients with myelodysplastic syndromes. J Clin Oncol (2011) 2.26
Single nucleotide polymorphism in the mutational hotspot of WT1 predicts a favorable outcome in patients with cytogenetically normal acute myeloid leukemia. J Clin Oncol (2009) 2.23
Long-term results after aortic valve-sparing operation (David I). Eur J Cardiothorac Surg (2012) 2.16
Methylene blue: the drug of choice for catecholamine-refractory vasoplegia after cardiopulmonary bypass? J Thorac Cardiovasc Surg (2003) 2.14
Total aortic arch replacement with a novel four-branched frozen elephant trunk graft: first-in-man results. Eur J Cardiothorac Surg (2012) 2.11
Persistent malignant stem cells in del(5q) myelodysplasia in remission. N Engl J Med (2010) 2.11
Acute treatment of ST-segment-elevation myocardial infarction: is there a role for the cardiac surgeon? Ann Thorac Surg (2009) 2.11
The ARCH Projects: design and rationale (IAASSG 001). Eur J Cardiothorac Surg (2013) 2.06
Long-term cardiac allograft valves after heart transplant are functionally and structurally preserved, in contrast to homografts and bioprostheses. J Heart Valve Dis (2006) 2.04
Gene therapy for Wiskott-Aldrich syndrome--long-term efficacy and genotoxicity. Sci Transl Med (2014) 2.00
MicroRNA-24 regulates vascularity after myocardial infarction. Circulation (2011) 1.98
Safety and efficacy of bioabsorbable magnesium alloy stents in porcine coronary arteries. Catheter Cardiovasc Interv (2006) 1.97
The impact of therapy-related acute myeloid leukemia (AML) on outcome in 2853 adult patients with newly diagnosed AML. Blood (2010) 1.96
TGFBR1 and TGFBR2 mutations in patients with features of Marfan syndrome and Loeys-Dietz syndrome. Hum Mutat (2006) 1.93
Vascular complications in patients undergoing femoral cannulation for extracorporeal membrane oxygenation support. Ann Thorac Surg (2011) 1.81
Ascending aortic cannulation in acute aortic dissection type A: the Hannover experience. Eur J Cardiothorac Surg (2008) 1.80
Monitoring of minimal residual disease in NPM1-mutated acute myeloid leukemia: a study from the German-Austrian acute myeloid leukemia study group. J Clin Oncol (2011) 1.79
Health-related quality of life and exercise tolerance in recipients of heart transplants and left ventricular assist devices: a prospective, comparative study. J Heart Lung Transplant (2010) 1.78
The generation of six clinical-grade human embryonic stem cell lines. Cell Stem Cell (2007) 1.75
Acquired von Willebrand syndrome in patients with an axial flow left ventricular assist device. Circ Heart Fail (2010) 1.75
Normothermic perfusion of donor lungs for preservation and assessment with the Organ Care System Lung before bilateral transplantation: a pilot study of 12 patients. Lancet (2012) 1.75
Elephant trunk procedure 27 years after Borst: what remains and what is new? Eur J Cardiothorac Surg (2011) 1.73
Ascending aortic cannulation for Stanford type A acute aortic dissection: another option. J Thorac Cardiovasc Surg (2003) 1.73
Sutureless Perceval S aortic valve replacement: a multicenter, prospective pilot trial. J Heart Valve Dis (2009) 1.70
Increased chimerism of bronchial and alveolar epithelium in human lung allografts undergoing chronic injury. Am J Pathol (2003) 1.69
Outcome of high-risk acute myeloid leukemia after allogeneic hematopoietic cell transplantation: negative impact of abnl(17p) and -5/5q-. Blood (2012) 1.68
Enhanced cardiomyogenesis of human embryonic stem cells by a small molecular inhibitor of p38 MAPK. Differentiation (2007) 1.66
Impact of additional cytogenetic aberrations at diagnosis on prognosis of CML: long-term observation of 1151 patients from the randomized CML Study IV. Blood (2011) 1.65
Clonal evolution in relapsed NPM1-mutated acute myeloid leukemia. Blood (2013) 1.62
Total aortic arch replacement with the frozen elephant trunk technique: 10-year follow-up single-centre experience. Eur J Cardiothorac Surg (2013) 1.61
Long-term outcome after pulmonary retransplantation. J Thorac Cardiovasc Surg (2006) 1.59
Renovascular hypertension by two-kidney one-clip enhances endothelial progenitor cell mobilization in a p47phox-dependent manner. J Hypertens (2008) 1.57
Chemically defined medium supporting cardiomyocyte differentiation of human embryonic stem cells. Differentiation (2008) 1.56
Prognostic impact of IDH2 mutations in cytogenetically normal acute myeloid leukemia. Blood (2010) 1.56
Cardiac retransplantation: is it justified in times of critical donor organ shortage? Long-term single-center experience. Eur J Cardiothorac Surg (2008) 1.54
Extended pulmonary resections of advanced thoracic malignancies with support of cardiopulmonary bypass. Eur J Cardiothorac Surg (2005) 1.54
Extended criteria donor lungs and clinical outcome: results of an alternative allocation algorithm. J Heart Lung Transplant (2013) 1.53
Predictors of aneurysmal formation after surgical correction of aortic coarctation. J Am Coll Cardiol (2002) 1.51
Isolated surgical aortic valve replacement after previous coronary artery bypass grafting with patent grafts: is this old-fashioned technique obsolete? Eur J Cardiothorac Surg (2008) 1.51
Sutureless perceval aortic valve replacement: results of two European centers. Ann Thorac Surg (2012) 1.51
Pulmonary preservation with LPD and celsior solution in porcine lung transplantation after 24 h of cold ischemia. Eur J Cardiothorac Surg (2004) 1.51
The impact of deep and moderate body temperatures on end-organ function during hypothermic circulatory arrest. Eur J Cardiothorac Surg (2011) 1.51
Surfactant function in lung transplantation after 24 hours of ischemia: advantage of retrograde flush perfusion for preservation. J Thorac Cardiovasc Surg (2002) 1.49
Higher frequencies of BCRP+ cardiac resident cells in ischaemic human myocardium. Eur Heart J (2012) 1.49
C1-esterase-inhibitor for primary graft dysfunction in lung transplantation. Transplantation (2014) 1.49
Anticoagulation for prosthetic heart valves during pregnancy: is low-molecular-weight heparin an alternative? Eur J Cardiothorac Surg (2002) 1.49
Total aortic arch replacement with the elephant trunk technique: single-centre 30-year results. Eur J Cardiothorac Surg (2013) 1.48
Scalable expansion of human pluripotent stem cells in suspension culture. Nat Protoc (2011) 1.46
Thrombus formation in a HeartMate II left ventricular assist device. J Thorac Cardiovasc Surg (2008) 1.46
A multi-modal intervention in management of left ventricular assist device outpatients: dietary counselling, controlled exercise and psychosocial support. Eur J Cardiothorac Surg (2012) 1.46
Hypothermic circulatory arrest with moderate, deep or profound hypothermic selective antegrade cerebral perfusion: which temperature provides best brain protection? Eur J Cardiothorac Surg (2006) 1.44
Microbial adhesion on membrane oxygenators in patients requiring extracorporeal life support detected by a universal rDNA PCR test. ASAIO J (2013) 1.44
Myocardial tissue engineering: the extracellular matrix. Eur J Cardiothorac Surg (2008) 1.43
Treatment of patients with recurrent or persistent infection of cardiac implantable electronic devices. Europace (2010) 1.43
One-year outcomes of the Surgical Treatment of Aortic Stenosis With a Next Generation Surgical Aortic Valve (TRITON) trial: a prospective multicenter study of rapid-deployment aortic valve replacement with the EDWARDS INTUITY Valve System. J Thorac Cardiovasc Surg (2012) 1.43
Economic aspects of deep sternal wound infections. Eur J Cardiothorac Surg (2009) 1.42
The frozen elephant trunk technique: a new treatment for thoracic aortic aneurysms. J Thorac Cardiovasc Surg (2003) 1.42
Prevalence of CCR5Delta32 polymorphism in long-term survivors of heart transplantation. Transpl Immunol (2006) 1.42
Immunoglobulin G treatment of postcardiac surgery patients with score-identified severe systemic inflammatory response syndrome--the ESSICS study. Crit Care Med (2008) 1.42
Happy heart syndrome: role of positive emotional stress in takotsubo syndrome. Eur Heart J (2016) 1.42
Thromboelastometry-guided administration of fibrinogen concentrate for the treatment of excessive intraoperative bleeding in thoracoabdominal aortic aneurysm surgery. J Thorac Cardiovasc Surg (2009) 1.41
Epithelial and Erythrocyte Microvesicles From Bronchoalveolar Lavage Fluid Are Elevated and Associated With Outcome in Chronic Lung Allograft Dysfunction. Transplantation (2015) 1.41
A PET/CT-follow-up imaging study to differentiate takotsubo cardiomyopathy from acute myocardial infarction. Int J Cardiovasc Imaging (2013) 1.40
Allogeneic CD4+CD25high T cells regulate obliterative bronchiolitis of heterotopic bronchus allografts in both porcinized and humanized mouse models. Transplantation (2015) 1.40
No evidence of transdifferentiation of human endothelial progenitor cells into cardiomyocytes after coculture with neonatal rat cardiomyocytes. Circulation (2006) 1.39
Registry for the Evaluation of the PROgnostic value of a novel integrated imaging approach combining Single Photon Emission Computed Tomography with coronary calcification imaging (REPROSPECT). Eur Heart J Cardiovasc Imaging (2012) 1.39
Insulin redirects differentiation from cardiogenic mesoderm and endoderm to neuroectoderm in differentiating human embryonic stem cells. Stem Cells (2007) 1.38
Clinical relevance of intracranial high intensity transient signals in patients following prosthetic aortic valve replacement. Eur J Cardiothorac Surg (2002) 1.38
Myocardial infarction following coronary artery bypass graft surgery increases healthcare resource utilization. Crit Care Med (2007) 1.35
Hypothermic circulatory arrest with selective antegrade cerebral perfusion in ascending aortic and aortic arch surgery: a risk factor analysis for adverse outcome in 501 patients. J Thorac Cardiovasc Surg (2008) 1.35
Bridge to lung transplantation with the novel pumpless interventional lung assist device NovaLung. J Thorac Cardiovasc Surg (2006) 1.33
Apoptosis repressor with caspase recruitment domain is required for cardioprotection in response to biomechanical and ischemic stress. Circulation (2006) 1.33
IDH1 mutations in patients with myelodysplastic syndromes are associated with an unfavorable prognosis. Haematologica (2010) 1.32
Clonal heterogeneity in the 5q- syndrome: p53 expressing progenitors prevail during lenalidomide treatment and expand at disease progression. Haematologica (2009) 1.31
Monosomal karyotype in adult acute myeloid leukemia: prognostic impact and outcome after different treatment strategies. Blood (2011) 1.30
Intramural hematoma of the aorta: predictors of progression to dissection and rupture. Circulation (2003) 1.30
Induced pluripotent stem cell (iPSC)-derived Flk-1 progenitor cells engraft, differentiate, and improve heart function in a mouse model of acute myocardial infarction. Eur Heart J (2011) 1.29